Saluda Medical Accelerates Former CEO’s Restricted Stock Vesting
Saluda Medical says restricted stock units held by former CEO Barry Regan vested early after his employment was terminated without cause. The resulting depositary interests will be subject to voluntary escrow until December 2027, and the company will apply to have them quoted.
Closing price · 2026-10-27: $0.250 · +0.00%